GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Fredun Pharmaceuticals Ltd

Fredun Pharma allots 44,000 Equity Shares via Warrant Conversion

FUNDRAISE ▲ Positive Development LOW RISK
📅 Filed on BSE: 23 Oct 2026, 06:30 PM IST  ·  BSE ID: d5cf1073-a5b6-4164-8c9e-63c19376ca18
View Original BSE Filing (PDF)
💡
In Simple Terms
Fredun Pharma issued new shares to investors who converted their warrants, a process adjusted for a recent bonus share distribution.
🤖 AI Summary
  • Fredun Pharma allots 44,000 equity shares upon conversion of 14,667 warrants.
  • Allotment is to three non-promoter investors: Divya Aggarwal, Indu Ramanlal Golecha, Sahil Dhir.
  • Warrants were initially allotted December 29, 2025, with terms adjusted for a 1:2 bonus issue.
  • The allotted equity shares will rank pari passu with existing shares of the company.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Total number of Equity Shares allotted
44,000
Number of convertible warrants converted
14,667
Face value of Equity Shares
Rs. 10/- each
Bonus Issue Ratio
1:2
Number of Non-Promoter Investors
3
🏢 How This Affects the Company
💰
Financial Impact
The conversion of warrants injects funds into the company, increasing its equity base. This event settles outstanding convertible instruments.
👥 What This Means For Shareholders
✅
Action Required
No action is required from existing shareholders regarding this allotment.
👤
Who Is Affected
The three named non-promoter allottees are directly affected by receiving newly issued equity shares.
🔍
Management Signal
This demonstrates management's execution of prior financial commitments related to warrant conversions.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Quarterly financial results for Q3 FY27.
Any future announcements regarding further fund-raising activities.
Updates on business development or expansion plans.
LOW RISK Standard procedural allotment following prior warrant issuance and bonus adjustment.
💡 Investor Takeaway
Fredun Pharma completed the allotment of 44,000 equity shares to three non-promoter investors via warrant conversion, adjusted for a 1:2 bonus issue.
⚖️ Strengths & Concerns

✅ Positives

  • Conversion of outstanding warrants into equity settles existing financial obligations.
  • Allotted shares rank pari passu with existing equity, indicating no preferential treatment post-allotment.
📅 Company Track Record
Previous filings show the promoter completed conversion of 40,000 warrants for Rs. 3.75 Crore in April 2026, settling all promoter warrants.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
How many equity shares did Fredun Pharma allot?
Fredun Pharma allotted 44,000 equity shares upon conversion of warrants.
Who received the newly allotted equity shares?
The shares were allotted to three non-promoter investors: Divya Aggarwal, Indu Ramanlal Golecha, and Sahil Dhir.
What was the basis for the share allotment?
The allotment was based on the conversion of 14,667 convertible warrants into equity shares, adjusted for a 1:2 bonus issue.
When were the original warrants allotted?
The convertible warrants were initially allotted on December 29, 2025.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.